Clinical Examination of Cavovarus Feet
Identification of Forefoot Morphotypes in Cavovarus Feet Without the Need for Specialised Software
2 other identifiers
observational
30
1 country
1
Brief Summary
Cavovarus feet are complex deformities in multiple planes. There is little consensus on the best way to address deformities. Furthermore there are various different phenotypes and we have previously described 4 distinct forefoot morphotypes that exist. It has been hypothesised that the various morphotypes could benefit from differing surgical strategies. However, identification of forefoot morphotypes has only been possible thus far using specialised semi-automated software and 3D animating software to manually identify morphotypes. It is therefore not straightforward to identify which patients may benefit from which surgery and this is not translatable to surgeons outside of a specialist centre. The utility of this classification has been thus far limited to research. There is a burning need to explore ways in which identification of forefoot morphotypes can be translated to other centres using techniques such as basic imaging or clinical examination to identify patients with different morphotypes. At Royal National Orthopaedic Hospital (RNOH) we have a large, complex cohort of patients with neuromuscular foot and ankle deformity and cavovarus feet. We also have access to advanced imaging techniques which we employ in routine care of our patients. We further have access to the software and previous research tools used to identify forefoot morphotypes. We have for many years been examining cavovarus feet and documenting the various clinical findings. We also run teaching clinics combined with registrars where patients are routinely examined as part of routine care and pre-operative work up. Therefore we are ideally and uniquely placed to carry out this research which is an extension of our previous work. Our primary aim is to identify a reproducible method of distinguishing between the various forefoot morphotypes in cavovarus feet in patients with Charcot Marie Tooth disease (CMT). This will include investigating the utility of clinical examination and manual measurements (without specialised software) on weightbearing CT (WBCT). We will also aim to examine the reproducibility of any techniques such as clinical examination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 28, 2026
CompletedFirst Submitted
Initial submission to the registry
June 8, 2026
CompletedFirst Posted
Study publicly available on registry
June 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
June 12, 2026
June 1, 2026
2 months
June 8, 2026
June 8, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Assessment of reproducibility of clinical examination
6 months
Study Arms (1)
Cavovarus Feet
Patients with cavovarus feet and Charcot Marie Tooth
Interventions
Eligibility Criteria
Patients with CMT and cavovarus feet
You may qualify if:
- Adult patients aged ≥ 18 years
- Clinical diagnosis of cavovarus foot deformity, AND confirmed Charcot-Marie-Tooth disease or other hereditary sensorimotor neuropathy
- Already under the care of the Foot \& Ankle Unit at RNOH.
- Additionally, for PROSPECTIVE element:
- Capacity to provide written informed consent
- Additionally, for the RETROSPECTIVE element:
- Previously assessed for cavovarus feet at RNOH
- Forefoot morphotype previously identified using Disior Bonelogic software
- Clinical examination findings documented in medical notes.
You may not qualify if:
- Previous surgery to the hindfoot or midfoot
- Age under 18 years
- For the PROSPECTIVE element:
- Unable to consent
- For the RETROSPECTIVE element:
- Participant has previously withdrawn consent for use of their data in line with NHS Opt-out
- Insufficient clinical examination data recorded in medical notes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal National Orthopaedic Hospital
Stanmore, HA7 4LP, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karan Malhotra
Consultant Orthopaedic Surgeon
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2026
First Posted
June 12, 2026
Study Start
May 28, 2026
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
June 12, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share